BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10741546)

  • 1. Parallel synthesis of a series of subtype-selective NMDA receptor antagonists.
    Gregory TF; Wright JL; Wise LD; Meltzer LT; Serpa KA; Konkoy CS; Whittemore ER; Woodward RM
    Bioorg Med Chem Lett; 2000 Mar; 10(6):527-9. PubMed ID: 10741546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines.
    Wright JL; Gregory TF; Bigge CF; Boxer PA; Serpa K; Meltzer LT; Wise LD; Cai SX; Hawkinson JE; Konkoy CS; Whittemore ER; Woodward RM; Zhou ZL
    J Med Chem; 1999 Jul; 42(13):2469-77. PubMed ID: 10395488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.
    Guzikowski AP; Tamiz AP; Acosta-Burruel M; Hong-Bae S; Cai SX; Hawkinson JE; Keana JF; Kesten SR; Shipp CT; Tran M; Whittemore ER; Woodward RM; Wright JL; Zhou ZL
    J Med Chem; 2000 Mar; 43(5):984-94. PubMed ID: 10715162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines.
    Wright JL; Gregory TF; Kesten SR; Boxer PA; Serpa KA; Meltzer LT; Wise LD; Espitia SA; Konkoy CS; Whittemore ER; Woodward RM
    J Med Chem; 2000 Sep; 43(18):3408-19. PubMed ID: 10978188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.
    Pinard E; Alanine A; Bourson A; Büttelmann B; Gill R; Heitz M; Jaeschke G; Mutel V; Trube G; Wyler R
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2173-6. PubMed ID: 11514163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective N-methyl-D-aspartate receptor antagonists: benzimidazalone and hydantoin as phenol replacements.
    Schelkun RM; Yuen PW; Serpa K; Meltzer LT; Wise LD; Whittemore ER; Woodward RM
    J Med Chem; 2000 May; 43(9):1892-7. PubMed ID: 10794706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and resolution of racemic eliprodil and evaluation of the enantiomers of eliprodil as NMDA receptor antagonists.
    Pabel J; Höfner G; Wanner KT
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1377-80. PubMed ID: 10890168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.
    Zhou ZL; Cai SX; Whittemore ER; Konkoy CS; Espitia SA; Tran M; Rock DM; Coughenour LL; Hawkinson JE; Boxer PA; Bigge CF; Wise LD; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Jul; 42(15):2993-3000. PubMed ID: 10425109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of subtype-selective NMDA receptor ligands: 4-benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists.
    Wright JL; Gregory TF; Boxer PA; Meltzer LT; Serpa KA; Wise LD
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2815-8. PubMed ID: 10522697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
    Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: a novel antagonist at the 1A/2B NMDA receptor subtype.
    Tamiz AP; Whittemore ER; Schelkun RM; Yuen PW; Woodward RM; Cai SX; Weber E; Keana JF
    Bioorg Med Chem Lett; 1998 Jan; 8(2):199-200. PubMed ID: 9871654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.
    Tamiz AP; Whittemore ER; Zhou ZL; Huang JC; Drewe JA; Chen JC; Cai SX; Weber E; Woodward RM; Keana JF
    J Med Chem; 1998 Aug; 41(18):3499-506. PubMed ID: 9719603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists.
    Beinat C; Banister S; Moussa I; Reynolds AJ; McErlean CS; Kassiou M
    Curr Med Chem; 2010; 17(34):4166-90. PubMed ID: 20939817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses, activity and modeling studies of 3- and 4-(sulfo- and sulfonamidoalkyl)pyridine and piperidine-2-carboxylic acid derivatives as analogs of NMDA receptor antagonists.
    el Hadri A; Maldivi P; Leclerc G; Rocher JP
    Bioorg Med Chem; 1995 Sep; 3(9):1183-201. PubMed ID: 8564410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore.
    Borza I; Domány G
    Curr Top Med Chem; 2006; 6(7):687-95. PubMed ID: 16719809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.
    Pinard E; Alanine A; Bourson A; Büttelmann B; Heitz M; Mutela Ramanjit Gill V; Trube G; Wyler R
    Bioorg Med Chem Lett; 2002 Sep; 12(18):2615-9. PubMed ID: 12182873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a series of γ-amino alcohols comprising an N-methyl isoindoline moiety and their evaluation as NMDA receptor antagonists.
    Müller A; Höfner G; Renukappa-Gutke T; Parsons CG; Wanner KT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5795-9. PubMed ID: 21875803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.